Attempted Suicide Short Intervention Program: a Randomized Controlled Trial
EASI
Evaluation of ASSIP - Attempted Suicide Short Intervention Program: a Randomized Controlled Trial
1 other identifier
interventional
100
1 country
1
Brief Summary
"Attempted Suicide Short Intervention Program" (ASSIP) is a brief psychotherapy intervention after suicide attempts in psychiatric patients. The study aims to analyse the efficacy in a controlled trial by comparing number of patients with suicide attempts in a control group with treatment as usual and an intervention group with treatment as usual and ASSIP intervention. Further, the study aims at indentifying electrophysiological, sociodempgraphical or smartphone-derived parameters for prediction of further suicide attempts.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 1, 2018
CompletedFirst Posted
Study publicly available on registry
November 6, 2018
CompletedStudy Start
First participant enrolled
December 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2023
CompletedMay 8, 2024
May 1, 2024
4.2 years
November 1, 2018
May 6, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
suicide/attempted suicide
number of patients with attempted suicide or suicide
12 months
Secondary Outcomes (4)
Number of toal suicide attempts
3,6,12 months
Hospitalization rates
12 months
EEG-vigilance
baseline
ECG Heart Rate Variability
baseline
Study Arms (2)
ASSIP + TAU goup
EXPERIMENTALASSIP psychotherapy intervention + treatment as usual (TAU)
TAU
NO INTERVENTIONTreatment as usual
Interventions
Three PSychotherapy Sessions plus after 3/6/9/12 months individualized letters
Eligibility Criteria
You may qualify if:
- Informed Consent as documented by signature (Appendix Informed Consent Form)
- Age 18 or older
- Treatment in and outpatient clinic of the University Hospital of Psychiatry Zurich, a daycare clinic or on a ward of the University Hospital of Psychiatry Zurich
- Able and willing to comply with all study requirements, especially being able to participate and understand psychotherapy sessions
You may not qualify if:
- Acute psychosis with delusion and/or hallucination
- Dementia
- Insufficient ability to communicate in German language
- Chronic self-harming behaviour without a direct intention of suicide (Wolfersdorf \& Etzersdorfer, 2011)
- Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant,
- Current electroconvulsive therapy (do to interference between cognitive side effects and psychotherapeutic intervention)
- Participation in another study with investigational drug within the 30 days preceding and during the present study,
- Previous enrolment into the current study,
- Enrolment of the investigator, his/her family members, employees and other dependent persons,
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department for Psychiatry, University Zurich
Zurich, Switzerland
Related Publications (2)
Gysin-Maillart A, Schwab S, Soravia L, Megert M, Michel K. A Novel Brief Therapy for Patients Who Attempt Suicide: A 24-months Follow-Up Randomized Controlled Study of the Attempted Suicide Short Intervention Program (ASSIP). PLoS Med. 2016 Mar 1;13(3):e1001968. doi: 10.1371/journal.pmed.1001968. eCollection 2016 Mar.
PMID: 26930055BACKGROUNDWitt KG, Hetrick SE, Rajaram G, Hazell P, Taylor Salisbury TL, Townsend E, Hawton K. Psychosocial interventions for self-harm in adults. Cochrane Database Syst Rev. 2021 Apr 22;4(4):CD013668. doi: 10.1002/14651858.CD013668.pub2.
PMID: 33884617DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sebastian Olbrich
Department for Psychiatry, Psychotherapy and Psychosomatics, University Zurich
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Deputy Head of Center for Social Psychiatry
Study Record Dates
First Submitted
November 1, 2018
First Posted
November 6, 2018
Study Start
December 1, 2018
Primary Completion
February 28, 2023
Study Completion
November 1, 2023
Last Updated
May 8, 2024
Record last verified: 2024-05